Rheumatoid Arthritis (RA) is an autoimmune disorder causing inflammation in the joints. Common treatments include Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Disease-modifying anti-rheumatic drugs (DMARDs) and biologic agents, all aiming to reduce pain, swelling, and joint damage.
Rheumatoid Arthritis (RA) is an autoimmune disorder causing inflammation in the joints. Common treatments include Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Disease-modifying anti-rheumatic drugs (DMARDs) and biologic agents, all aiming to reduce pain, swelling, and joint damage.
Austria's Rheumatoid Arthritis treatment consists of DMARDs (Disease-Modifying Antirheumatic Drugs) and biologics, such as methotrexate, infliximab, and adalimumab. These medications aim to reduce inflammation and prevent joint damage.
Austria's healthcare system is universal and provides comprehensive coverage for residents. The cost of these treatments can vary based on individual insurance plans, but generally, patients with compulsory health insurance pay a portion of the costs.